High plasma level of factor VIII - An important risk factor for venous thromboembolism -

Circulation Journal

Volumn 75, Issue 6, 2011, Pages 1472-1475

  Ota, Satoshi ^a   Yamada, Norikazu ^a   Ogihara, Yoshito ^a   Tsuji, Akihiro ^a   Ishikura, Ken ^a   Nakamura, Mashio ^a   Wada, Hideo ^a   Ito, Masaaki ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Deep vein thrombosis; Factor VIII; Pulmonary thromboembolism; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; JAPANESE; MALE; OBSERVATIONAL STUDY; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK FACTOR; VENOUS THROMBOEMBOLISM;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FACTOR VIII; FEMALE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UP-REGULATION; VENOUS THROMBOEMBOLISM;

EID: 79957724437     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-1051     Document Type: Article

References (29)

1. Sakuma M, Nakamura M, Yamada N, Ota S, Shirato K, Nakano T, et al. Venous thromboembolism: Deep vein thrombosis with pulmonary embolism, deep vein thrombosis alone, and pulmonary embolism alone. Circ J 2009; 73: 305-309.
2. Tokyo CCU Network Scientific Committee. Latest management and outcomes of major pulmonary embolism in the cardiovascular disease early transport system: Tokyo CCU Network. Circ J 2010; 74: 289-293.
3. Martinelli I. Risk factors in venous thromboembolism. Thromb Haemost 2001; 86: 395-403.
4. Bertina RM. Molecular risk factors for thrombosis. Thromb Haemost 1999; 82: 601-609.
5. Franco RF, Reitsma PH. Genetic risk factors of venous thrombosis. Hum Genet 2001; 109: 369-384.
6. Robetorye RS, Rodgers GM. Update on selected inherited venous thrombotic disorders. Am J Hematol 2001; 68: 256-268.
7. Rosendaal FR. Venous thrombosis: A multicausal disease. Lancet 1999; 353: 1167-1173.
8. Bertina RM. Genetic approach to thrombophilia. Thromb Haemost 2001; 86: 92-103.
9. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345: 152-155.
10. Kraaijenhagen RA, in't Anker PS, Koopman MM, Reitsma PH, Prins MH, van den Ende A, et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 2000; 83: 5-9.
11. O'Donnell J, Tuddenham EG, Manning R, Kemball-Cook G, Johnson D, Laffan M. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: Role of increased synthesis and relationship to the acute phase reaction. Thromb Haemost 1997; 77: 825-828.
12. Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000; 343: 457-462.
13. White RH, Zhou H, Murin S, Harvey D. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 2005; 93: 298-305.
14. de Visser MCH, Rosendaal FR, Bertina RM. A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis. Blood 1999; 93: 1271-1276.
15. Henkens CM, Bom VJ, van der Meer J. Lowered APC-sensitivity ratio related to increased factor VIII clotting activity. Thromb Haemost 1995; 74: 1198-1199.
16. Vlot AJ, Koppelman SJ, Bouma BN, Sixma JJ. Factor VIII and von Willebrand factor. Thromb Haemost 1998; 79: 456-465.
17. Brinkhous KM, Sandberg H, Garris JB, Mattson C, Palm M, Griggs T, et al. Purified human factor VIII procoagulant protein: Comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs. Proc Natl Acad Sci USA 1985; 82: 8752-8756.
18. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-1695.
19. Souto JC, Almasy L, Muniz-Diaz E, Soria JM, Borrell M, Bayén L, et al. Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol 2000; 20: 2024-2028.
20. Vlot AJ, Mauser-Bunschoten EP, Zarkova AG, Haan E, Kruitwagen CLJJ, Sixma JJ, et al. The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A. Thromb Haemost 2000; 83: 65-69.
21. Kamphuisen PW, Lensen R, Houwing-Duistermaat JJ, Eikenboom JCJ, Harvey M, Bertina RM, et al. Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia. Br J Haematol 2000; 109: 519-522.
22. O'Donnell J, Mumford AD, Manning RA, Laffan M. Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response. Thromb Haemost 2000; 83: 10-13.
23. Kamphuisen PW, Eikenboom JCJ, Bertina RM. Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol 2001; 21: 731-738.
24. Rosen S, Andersson M, Blombäck M, Hägglund U, Larrieu MJ, Wolf M, et al. Clinical application of a chromogenic substrate method for determination of factor VIII activity. Thromb Haemost 1985; 54: 818-823.
25. Tripodi A, Mannucci PM. Factor VIII activity as measured by an amidolytic assay compared with one-stage clotting assay. Am J Clin Pathol 1986; 86: 341-344.
26. van Dieijen G, van Dieijen-Visser MP, Franssen J, Hemker HC. Spectrophotometric method for the assay of human blood coagulation factor VIII. Haemostasis 1987; 17: 14-24.
27. Thompson SG, Duckert F, Haverkate F, Thomson JM. The measurement of haemostatic factors in 16 European laboratories: Quality assessment for the Multicentre ECAT Angina Pectoris Study: Report from the European Concerted Action on Thrombosis and Disabilities (ECAT). Thromb Haemost 1989; 61: 301-306.
28. Bobrow RS. Excess factor VIII: A common cause of hypercoagulability. J Am Board Fam Pract 2005; 18: 147-149.
29. Legnani C, Cosmi B, Cini M, Frascaro M, Guazzaloca G, Palareti G. High plasma levels of factor VIII and risk of recurrence of venous thrombosis. Br J Haematol 2004; 124: 504-510.